peppersite
Supplement

NAD+

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell, not a peptide. Cells use it to turn food into energy, repair DNA and power a family of enzymes called sirtuins, and it is studied in metabolism and aging research.

Researched for
LongevityMetabolic HealthCognitive SupportRecovery

At a glance

Type
Supplement
Evidence
Not yet audited here; the reference library calls it emerging
Reported amount
100 mg per Peptide Dosing Protocols. All 2 sources
Typical vial
750 mg in 7.5 mL

How much to draw

Full calculator →
Your draw
100units
1 mL on a U-100 insulin syringe
100 mg/mL7 doses per vial
Amount per dose

Opened on 100 mg, the figure Peptide Dosing Protocols reports for NAD+, and a 750 mg vial in 7.5 mL. A reported amount, not a recommendation. Change any number to match the vial in your hand. How to reconstitute a vial.

What sources report

Reference, not a recommendation

These are figures published elsewhere, reproduced with their source. Peppersite does not recommend an amount for NAD+ or for anything else, and nothing below has been checked against the study it came from.

250-750 mg per IV session; 300-1000 mg daily for oral precursors (NR/NMN)
Frequency
1-2x weekly IV (loading), monthly (maintenance); daily oral4-8 week loading phase IV; ongoing for oral precursors
Route
oral
Reported by
Peptide Protocol Wiki
Standard: 100 mg · Low: 50 mg · High: 200 mg
Frequency
2-3x weekly4-8 weeks · 4 weeks, then escalate to 100 mg weekly.
Route
SubQ
Reported by
Peptide Dosing Protocols
What it saysThe standard dose for NAD+ is 100 mg administered 2-3 times weekly.
Reconstitution, as reported
  • Normal saline (0.9% NaCl) 250-500 mL for IV
  • 7.5 mL BAC water for 750 mg vial
Not yet audited

We have not published an audit on NAD+. Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.

How it is thought to work

NAD+ levels fall with age, and the idea behind giving it is to raise them again. Researchers tie it to ATP production, DNA repair and sirtuin activity. Most published human trial evidence uses the oral precursors NR and NMN rather than injected NAD+ itself. A 2024 systematic review found insufficient high-quality evidence for routine use of NAD+ injected under the skin.

In technical termsNAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. Your body uses it to turn food into cellular energy (ATP), to fuel DNA repair, and to power a family of longevity-related enzymes called sirtuins. [Source: Peptide Dosing Protocols]

Reported side effects

Reported by users: with injection under the skin, stinging, burning, redness or temporary lumps at the site, along with nausea, headache or flushing early on, short-lived tiredness in the first few sessions, and disrupted sleep when it is given later in the day. With an IV drip, flushing and warmth, chest tightness or breathlessness, mild headache from short-lived widening of blood vessels, and a brief rise in heart rate, all more common when the infusion runs fast.

Not ruled out: long-term human safety data for high-dose injectable NAD+ remains limited. Active cancer is listed as a reason not to use it, because NAD+ supports cell growth. Liver and kidney markers are described as worth tracking in extended high-dose use.

Who should avoid it

People who are pregnant or breastfeeding: safety data is insufficient.

People with active cancer: NAD+ supports cell growth, potentially including in cancer cells, and sources call an oncologist's input essential.

People with severe liver or kidney impairment: high-dose use may add metabolic burden.

People with known hypersensitivity to the formulation or to preservatives in bacteriostatic water: listed as a reason to avoid it.

People taking high-dose niacin: the loads on the NAD+ pathway overlap and are flagged for clinician review.

People taking glucose-lowering medicines: NAD+ may increase insulin sensitivity over time, so closer glucose monitoring is described as prudent.

What gets monitored

Liver markers (ALT, AST) in extended high-dose protocols; glucose markers if also using glucose-lowering medications; sleep quality and timing; subjective energy and recovery from training. (reported by Peptide Dosing Protocols)

Common questions

Is NAD+ a peptide?

No. NAD+ is a coenzyme, not a peptide. It is grouped with peptide protocols because it shares the injectable research-use format and overlaps with peptide research goals around energy, recovery and longevity.

What do sources report as a starting amount for NAD+ injections?

Reported amounts and schedules for NAD+ differ by source, and peppersite does not recommend one. Each reported figure is listed in the dosing rows on this page, next to the source that reports it.

How do you reconstitute an NAD+ vial?

That depends on the vial size and how much water is added. The calculator on this page works out the draw for any combination, and the reconstitution guide covers the steps.

How much NAD+ do sources report per day?

Reported amounts and schedules for NAD+ differ by source, and peppersite does not recommend one. Each reported figure is listed in the dosing rows on this page, next to the source that reports it.

What are NAD+ injection side effects?

Common reports include stinging at the injection site, nausea, headache, flushing and short-term tiredness. Most are described as depending on how much is given and how fast.

Is NAD+ FDA-approved?

No. Injectable NAD+ is not FDA-approved as a therapeutic.

How long does NAD+ take to work?

People given NAD+ by IV commonly report energy and mental-clarity changes within 24 to 48 hours. Effects from injection under the skin may take longer. These are reports rather than trial endpoints.

What is the largest amount of NAD+ that has been studied?

Reported amounts and schedules for NAD+ differ by source, and peppersite does not recommend one. Each reported figure is listed in the dosing rows on this page, next to the source that reports it.

Sources

  1. 01Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications (2018)
  2. 02Conze D, Brenner C, Kruger CL. Safety and Metabolism of Long-term Administration of NIAGEN in Healthy Overweight Adults. Scientific Reports (2019)
  3. 03Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science (2021)
  4. 04Yi L, Maier AB, Tao R, et al. The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience (2023)
  5. 05Brakedal B, Dolle C, Riber F, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metabolism (2022)
  6. 06Dollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men. American Journal of Clinical Nutrition (2018)
  7. 07Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports (2019)
  8. 08Yoshino J, Baur JA, Imai SI. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism (2018)
  9. 09Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology (2021)
  10. 10Trammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications (2016)
  11. 11Braidy N, Liu Y. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Experimental Gerontology (2020)
  12. 12Hong W, Mo F, Zhang Z, et al. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Advances in Nutrition (2023)
  13. 13Evaluation of safety and effectiveness of NAD in different clinical conditions (systematic review). Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. American Journal of Physiology - Endocrinology and Metabolism (2024)
  14. 14ClinicalTrials.gov NCT07328100 — Efficacy and Safety of Coenzyme I (NAD) for Injection on Vascular Aging. ClinicalTrials.gov (2026)
  15. 15Cleveland Clinic Health Library NAD (Nicotinamide Adenine Dinucleotide) — function, anatomy, conditions and disorders. Cleveland Clinic (2026)

The reference sections on this page come from a compound library we import, not from our own review of the studies. Our own evidence grade appears only where an audit is linked. Research use only; nothing here is medical advice or a protocol.

Studied for the same things
Glutathione

Glutathione (GSH) is a small molecule built from three amino acids, cysteine, glycine and glutamate, made by nearly every cell and most of all by the liver. It has been studied in people for skin lightening, liver enzymes in fatty liver disease, and Parkinson's disease.

MOTS-c

MOTS-c is a short chain of 16 amino acids that cells build from mitochondrial DNA rather than from the DNA in the nucleus. Most of what is known about it comes from cell and animal work on metabolism, exercise capacity and insulin sensitivity.

Sermorelin Acetate

Sermorelin is a lab-made peptide that copies the first 29 amino acids of the body's own growth hormone-releasing hormone (GHRH). It has been studied in the growth hormone system, including FDA-era trials as a diagnostic agent and as a treatment for growth hormone deficiency in children.

Tesamorelin / Ipamorelin

This is a combination of two growth hormone compounds sold in a single vial: tesamorelin, a synthetic copy of growth hormone-releasing hormone, and ipamorelin, a ghrelin mimic that acts as a growth hormone secretagogue. It is sold for research use and is studied in the context of the growth hormone system, visceral fat and recovery.

Epitalon

Epitalon, also spelled epithalon, is a lab-made peptide of four amino acids (Ala-Glu-Asp-Gly), also called AEDG. It is studied mainly for aging, in cells, in animals and in older non-blinded human work on the related pineal extract.

GHK-Cu

GHK-Cu, or copper tripeptide-1, is a natural peptide of three amino acids bound to a copper ion, found in human blood plasma. It is studied for skin, hair and wound repair, mostly in cells and animals, with the strongest human evidence for topical use.